Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

AgelessRx vs Cielo

Two GLP-1 desks, one scoreboard. We put AgelessRx and Cielo head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 23 · Grade B

AgelessRx

Visit AgelessRx Full brief →
vs
No. 147 · Grade C

Cielo

Visit Cielo Full brief →

The verdict

AgelessRx takes this head-to-head.

AgelessRx scores 85 to 69 on our six-factor Brief Score — A longevity-leaning brand with one of the lowest tracked semaglutide stickers — but a thin disclosure on the rest.

That doesn't make Cielo a bad call — it's best for readers who want flat-rate compounded glp-1 at the lowest 3-month bundle prices. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
84
66
Supply Reliability
85
72
Transparency
82
72
Access Breadth
84
56
Clinical Oversight
84
80
Track Record
88
68
AgelessRxBrief Score 85 · 69Cielo

Price, coverage & the tracker

AgelessRxCielo
Brief Score85/100 (B)69/100 (C)
Semaglutide$139/moFrom $149/mo (all doses, compounded)
TirzepatideNot disclosedFrom $249/mo (all doses, compounded)
CoverageNot disclosedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

AgelessRx: Low tracked semaglutide sticker; tirzepatide price still undisclosed.

Cielo: New to the tracker on 1 August 2026. The published line reads From $149/mo (all doses, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.